Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Sep 15 2023

Full Issue

New Study Finds 'Exciting' Result In MDMA Treatment For PTSD: It's Safe

Stat says the study adds to a body of evidence supporting MDMA as a treatment for PTSD. The New York Times says the psychedelic is inching toward approval. Also in the news: Magic mushrooms may soon be legal in California, and thousands have signed up for an Oregon psilocybin tea experiment.

Stat: MDMA Is Safe And Effective Treatment For PTSD, Says New Study

MDMA is a safe and effective treatment for post-traumatic stress disorder in a racially and ethnically diverse population, according to the results of a study published Thursday in Nature Medicine. The research adds to the growing body of evidence supporting MDMA as a treatment for PTSD, and brings the psychedelic one step closer to potentially becoming the first to obtain Food and Drug Administration approval. (Merelli, 9/14)

The New York Times: MDMA Therapy For PTSD Inches Closer To U.S. Approval 

MDMA, also known as Ecstasy or Molly, has been an illegal substance since 1985, when the Drug Enforcement Administration classified it as a Schedule 1 drug, placing it in the highest category for controlled drugs that the agency deems of no medical use and that have a high potential for abuse. Before that, MDMA was administered by an estimated hundreds of therapists in North America and Europe for couples counseling, personal growth and to address trauma. (Nuwer, 9/14)

Also —

KCRW: Magic Mushrooms Might Soon Be Legal In California. Who Benefits? 

Psychedelics have been getting a lot of attention recently. As the drug war cools down and the stigma dissipates, new research has revealed the potential of these substances to support transformational mental health care. The state of Oregon and the cities of Santa Cruz and Oakland have already decriminalized certain psychedelics, and a new bill that just passed the California legislature would do the same in the Golden State. (Reed, 9/12)

AP: Magic Mushrooms: Thousands Sign Up For Oregon's Psilocybin Experiment

Psilocybin tea, wind chimes and a tie-dye mattress await those coming to an office suite in Eugene to trip on magic mushrooms. For roughly six hours, adults over 21 can experience what many users describe as vivid geometric shapes, a loss of identity and a oneness with the universe. Epic Healing Eugene — Oregon’s first licensed psilocybin service center — opened in June, marking the state’s unprecedented step in offering the mind-bending drug to the public. The center now has a waitlist of more than 3,000 names, including people with depression, PTSD or end-of-life dread. (Selsky, 9/15)

Big Think: How Psychedelics May Therapeutically Alter The Link Between Your Two “Selves” 

Interoception, the body's sense of its internal state, might be key to understanding consciousness and the benefits of psychedelic therapy. (Brigs, 9/13)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF